Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05814666 |
|---|---|
| Brief Title: | Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC (PEMDA-HN) |
| First Submitted : | March 10, 2023 |
| First Submitted that Met QC Criteria : | April 3, 2023 |
| First Posted : | April 18, 2023 |
| Last Update Submitted that Met QC Criteria : | April 8, 2024 |
| Last Update Posted : | April 10, 2024 |